\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes HealthThe EU-funded partnership ERA4Health (Horizon Europe) is conducting a comprehensive survey to identify the obstacles researchers encounter when turning their research into practical applications in four key areas:
- Nutrition & Lifestyle-related Diseases
- Cardiovascular Diseases
- Nanomedicine
- Public Health & Prevention
The survey only takes 5 to 10 minutes. Your feedback will help the partnership to create solutions to overcome the identified barriers.
To access the survey please use the following link: https://ec.europa.eu/eusurvey/runner/ERA4H_WP19
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
